V-012THORACOSCOPIC MEDIASTINAL LYMPH NODE DISSECTION FOR LUNG CANCER BY AN ENERGY DEVICE

Objectives We evaluate the feasibility of thoracoscopic mediastinal lymph node dissection for lung cancer by an energy device. Methods We performed VATS lobectomy and mediastinal lymph node dissection with 2 access windows both 3-cm lengths and one camera port completely under thoracoscopic view. We...

Full description

Saved in:
Bibliographic Details
Published in:Interactive cardiovascular and thoracic surgery Vol. 17; no. suppl_1; p. S4
Main Authors: Nishioka, Kiyonori, Iwazawa, T.
Format: Journal Article
Language:English
Published: Oxford University Press 01-07-2013
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives We evaluate the feasibility of thoracoscopic mediastinal lymph node dissection for lung cancer by an energy device. Methods We performed VATS lobectomy and mediastinal lymph node dissection with 2 access windows both 3-cm lengths and one camera port completely under thoracoscopic view. We used an energy device called Ligasure blunt tip®(Covidien), which is very convenient and safe, especially to dissect the mediastinal lymph node. Now we present a video of thoracoscopic superior mediastinal lymph node dissection for lung cancer after right upper lobectomy by Ligasure blunt tip®. In addition, we examined the perioperative data of these operations. Results Up to now, we have performed the aforementioned operation for 23 lung cancer patients. Perioperative data were as follows: Median duration of the mediastinal lymph nodes dissection: 43 min (range 25-65). Median blood loss including lobectomy: 50 g (range 10-160). Median day of drain removed: 3rd (range 1-8) postoperative day. Median dissected lymph nodes: 10 (5-20). Complication: 1 minor chylothorax recovered by low fat diet. The drain was removed at 8th POD. Conclusions Thoracoscopic mediastinal lymph node dissection for lung cancer by Ligasure blunt tip® is feasible. Disclosure All authors have declared no conflicts of interest.
ISSN:1569-9293
1569-9285
DOI:10.1093/icvts/ivt288.12